1. Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer

   • Omid Hamid
   • Brianna Hoffner
   • Richard D. Carvajal

   Review Open access 15 July 2017 Pages: 1249 - 1264

   

2. Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case–control study in Northern China

   • Sheng Han
   • Jian Deng
   • Anhua Wu

   Original Article 18 May 2017 Pages: 1265 - 1273

   

3. CD45RA⁻Foxp3^high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma

   • Fumie Ihara
   • Daiju Sakurai
   • Yoshitaka Okamoto

   Original Article 27 May 2017 Pages: 1275 - 1285

   

4. Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro

   • Sarah J. Storr
   • Sabreena Safuan
   • Stewart G. Martin

   Original Article Open access 27 May 2017 Pages: 1287 - 1294

   

5. Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy

   • Simone Battella
   • M. Christina Cox
   • Gabriella Palmieri

   Original Article 29 May 2017 Pages: 1295 - 1306

   

6. In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells

   • Yildian Díaz-Rodríguez
   • Paulo Cordeiro
   • Michel Duval

   Original Article Open access 29 May 2017 Pages: 1307 - 1320

   

7. TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model

   • Fang Huang
   • Jiangbo Wan
   • Liyuan Ma

   Original Article 10 June 2017 Pages: 1321 - 1331

   

8. Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists

   • Tanja Lövgren
   • Dhifaf Sarhan
   • Rolf Kiessling

   Original Article Open access 10 June 2017 Pages: 1333 - 1344

   

9. Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer

   • Guru Sonpavde
   • John D. McMannis
   • Kevin M. Slawin

   Original Article 12 June 2017 Pages: 1345 - 1357

   

10. A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma

    • Sapna P. Patel
    • Dae Won Kim
    • Agop Y. Bedikian

    Original Article 13 June 2017 Pages: 1359 - 1366

    

11. Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions

    • Feng Xu
    • Alexander Sunderland
    • Yuwen Zhu

    Original Article 16 June 2017 Pages: 1367 - 1375

    

12. Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab

    • Markus V. Heppt
    • Ilana Goldscheider
    • Carola Berking

    Letter to the Editors 11 May 2017 Pages: 1377 - 1378

    

13. A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer

    • Weili Wang
    • Ping Liao
    • Yijing He

    Letter to the Editors 24 May 2017 Pages: 1379 - 1381